Toll-Like Receptor Signaling in Liver Ischemia and Reperfusion

REFERENCES

• Farmer DG, Amersi F, Kupiec-Weglinski JW, Current status of ischemia and reperfusion injury in the liver. Transplant Rev. 2000;14:106–126.
   Google Scholar
• Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific early and late chronic events after organ transplantation. Transplant Rev. 1996;10:108–127.
   Google Scholar
• Bamboat ZM, Balachandran VP, Ocuin LM, Toll- 320 like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 2010;51:621–632.
   PubMedGoogle Scholar
• Arumugam TV, Okun E, Tang SC, Toll-like receptors in ischemia-reperfusion injury. Shock 2009;32:4–16.
   PubMed Web of Science ®Google Scholar
• Thurman JM. Triggers of inflammation after renal ischemia-reperfusion. Clin Immunol. 2007;123:7–13.
   PubMed Web of Science ®Google Scholar
• Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepa- tic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290: G1083–G1088.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Signaling to NF-κB by Toll-like receptors. Trends Mol Med. 2007;13:460–469.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. TLR signaling. Semin Immunol. 2007;19:24–32.
   PubMed Web of Science ®Google Scholar
• Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117:979–987.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost. 2007;97:738–747.
   PubMed Web of Science ®Google Scholar
• Hadley JS, Wang JE, Michaels LC, Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass. Shock 2007;27:466–473.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang H, Ding A, HMGB1 signals through Toll-like receptor (TLR)4 and TLR2. Shock 2006;26:174–179.
   PubMed Web of Science ®Google Scholar
• Breslin JW, Wu MH, Guo M, Toll-like receptor 4 contributes to microvascular inflammation and barrier dysfunction in thermal injury. Shock 2008;29:349–355.
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in liver. Gastroenterology 2006;130:1886–1900.
   PubMed Web of Science ®Google Scholar
• Schumann RR, Tapping RI. Genomic variants of TLR1—it takes (TLR—) two to tango. Eur J Immunol. 2007;37: 2059–2062.
   PubMedGoogle Scholar
• Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008;42:145–151.
   PubMed Web of Science ®Google Scholar
• Tsujimoto H, Ono S, Efron PA, Role of Toll-like receptors in the development of sepsis. Shock 2008;29:315–321.
   PubMed Web of Science ®Google Scholar
• Horner AA, Redecke V, Raz E. Toll-like receptor ligands: hygiene, atopy and therapeutic implications. Curr Opin Allergy Clin Immunol. 2004;4:555–561.
   PubMed Web of Science ®Google Scholar
• Buwitt-Beckman U, Heine H, Wiesmuller KH, Toll-like receptor 6—independent signaling by diacylated lipopeptides. Eur J Immunol. 2005;35:851–856.
   Google Scholar
• Smith KD, Ozinsky A. Toll-like receptor 5 and the innate immune response to bacterial flagellin. Curr Top Microbiol Immunol. 2002;270:93–108.
   PubMed Web of Science ®Google Scholar
• Harada K, Ohira S, Isse K, Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related moeclules in cultured biliary epithelial cells. Lab Invest. 2003;83:1657–1667.
   PubMedGoogle Scholar
• Doughty LA, Carlton S, Galen B, Activation of common antiviral pathways can potentiate inflammatory responses to septic shock. Shock 2006;26:187–194.
   PubMedGoogle Scholar
• Hornung V, Barchet W, Schlee M, RNA recognition via TLR7 and TLR8. Handb Exp Pharmacol. 2008;183:71–86.
   Google Scholar
• Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007;220:251–269.
   PubMed Web of Science ®Google Scholar
• Mollen KP, Rahul JA, Tsung A, Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006;26:430–437.
   PubMed Web of Science ®Google Scholar
• Wagner H. Endogenous TLR ligands and autoimmunity. Adv Immunol. 2006;91:159–173.
   PubMed Web of Science ®Google Scholar
• Okamura Y, Watari M, Jerud ES, The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem. 2001;276:10229–10233.
   PubMed Web of Science ®Google Scholar
• Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J Immunol. 2001;167:2887–2894.
   PubMed Web of Science ®Google Scholar
• Toole BP. Hyaluronan is not just a goo! J Clin Invest. 2000;106:335–336.
   PubMed Web of Science ®Google Scholar
• Chang EJ, Kim HJ, Ha J, Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci. 2007;120:166–176.
   PubMed Web of Science ®Google Scholar
• Cohen-Sfady M, Nussbaum G, Pevsner-Fischer M, Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol. 2005;175:3594–3602.
   PubMed Web of Science ®Google Scholar
• Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol. 2004;76:514–519.
   PubMed Web of Science ®Google Scholar
• O'Neill LA, Bowie AG. The family of five: TIR-domain containing adaptors in Toll-like receptor signaling. Nat Rev Immunol. 2007;7:353–364.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol. 2004;4:499–511.
   PubMed Web of Science ®Google Scholar
• Takaoka A, Yanai H, Kondo S, Integral role of IRF5 in the gene induction programme activated by Toll-like receptors. Nature 2005;434:243–249.
   PubMed Web of Science ®Google Scholar
• Kawai T, Adachi O, Ogawa T, Unresponsiveness of MyD88-deficient mice to endotoxin immunity. Immunity 1999;11:115–122.
   PubMed Web of Science ®Google Scholar
• Horng T, Barton GM, Flavell RA, The adaptor molecule TIRAP provides signaling specificity for Toll-like receptors. Nature 2002;420:329–333.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato S, Hemmi H, Essential role for TIRAP in activation of the signaling cascade shared by TLR2 and TLR4. Nature 2002;420:324–329.
   PubMed Web of Science ®Google Scholar
• Hoebe K, Du X, Georgel P, Identification of LPS2 as a key transducer of MyD88-independent TIR signaling. Nature 2003;424:743–748.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato S, Hemmi H, Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003;301:640–643.
   PubMed Web of Science ®Google Scholar
• Arumugam TV, Shiels IA, Woodruff TM, The role of the complement system in ischemia-reperfusion injury. Shock 2004;21:401–409.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuijs VB, De Bruijn MT, Padbury RT, Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci. 2006;51:1087–1102.
   PubMedGoogle Scholar
• Phillips L, Toledo AH, Lopez-Neblina F, Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22:46–55.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Shen X, O'Connell R, Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol. 2004;173:7115–7119.
   PubMed Web of Science ®Google Scholar
• Walsh KB, Toledo AH, Rivera-Chavez FA, Inflammatory mediators of liver ischemia-reperfusion injury. Exp Clin Transplant. 2009;7:78–93.
   PubMed Web of Science ®Google Scholar
• Babbs CF. Role of iron ions in the genesis of reperfusion injury following successful cardiopulmonary resuscitation: preliminary data and a biochemical hypothesis. Ann Emerg Med. 1985;14:777–783.
   PubMed Web of Science ®Google Scholar
• Arumugam TV, Magnus T, Woodruff TM, Complement mediators in ischemia-reperfusion injury. Clin Chim Acta. 2006;374:33–45.
   PubMed Web of Science ®Google Scholar
• Arumugam TV, Granger DN, Mattson MP. Stroke and T-cells. Neuromolecular Med. 2005;7:229–242.
   PubMed Web of Science ®Google Scholar
• Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol. 2007;35:757–766.
   PubMed Web of Science ®Google Scholar
• Gewirtz AT. Intestinal epithelial Toll-like receptors: to protect. And serve? Curr Pharm Des. 2003;9:1–5.
   PubMed Web of Science ®Google Scholar
• Gibson DL, Ma C, Rosenberger CM, Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol. 2008;10:388–403.
   PubMed Web of Science ®Google Scholar
• Beg AA. Endogenous ligands of Toll-like receptors: implications for regulatory inflammatory and immune responses. Trends Immunol. 2002;23:509.
   PubMed Web of Science ®Google Scholar
• Shen XD, Ke B, Zhai Y, Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia-reperfusion injury. Am J Transplant. 2005;5:1793–1800.
   PubMedGoogle Scholar
• Ellett JD, Evans ZP, Atkinson C, Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury. Liver Transplantation. 2009;15:1101–1109.
   PubMedGoogle Scholar
• Tsung A, Klune JR, Zhang Z, HMGB1 release induced by liver ischemia involves Tolllike receptor 4-dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007;204:2913–2923.
   PubMed Web of Science ®Google Scholar
• King LA, Toledo AH, Rivera-Chavez FA, Role of p38 and JNK in liver ischemia and reperfusion. J Hepatobiliary Pancreat Surg. 2009;16:763–770.
   PubMedGoogle Scholar
• Tsung A, Hoffman RA, Izuishi K, Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol. 2005;175:7661–7668.
   PubMed Web of Science ®Google Scholar
• Liu S, Salyapongse AN, Geller DA, Hepatocyte Toll-like receptor 2 expression in vivo and in vitro: role of cytokines in induction of rat TLR2 gene expression by lipopolysaccharide. Shock 2000;14:361–365.
   PubMedGoogle Scholar
• Matsumura T, Ito A, Takii T, Endotoxin and cytokine regulation of TLR2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res. 2000;20:915–921.
   PubMed Web of Science ®Google Scholar
• Tsung A, Sahai R, Tanaka H, The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005;201:1135–1143.
   PubMed Web of Science ®Google Scholar
• Matsumura T, Degawa T, Takii T, TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 2003;109:127–136.
   PubMedGoogle Scholar
• Zhang JX, Wu HS, Wang L, TLR2 mRNA up-regulation in ischemic lobes in mouse partial hepatic ischemia/reperfusion injury model. J Huazhong Univ Sci Technolog Med Sci. 2004;24:144–146.
   PubMedGoogle Scholar
• Yang RB, Mark MR, Gray A, Toll-like receptor 2 mediates lipopolysaccharide-induced cellular signaling. Nature 1998;395:284.
   PubMed Web of Science ®Google Scholar
• Galloway E, Shin T, Huber N, Activation of hepatocytes by extracellular heat shock protein 72. Am J Physiol Cell Physiol. 2008;295:C514–C520.
   PubMedGoogle Scholar
• Hemmi H, Takeuchi O, Kawai T, A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740–745.
   PubMed Web of Science ®Google Scholar
• Yasuda K, Yu P, Kirschning CJ, Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and independent pathways. J Immunol. 2005;174:6129–6139.
   PubMed Web of Science ®Google Scholar